| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/07/2011 | US20110082156 Fatty acid acipimox derivatives and their uses |
| 04/07/2011 | US20110082144 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| 04/07/2011 | US20110082142 Selective kinase inhibitors |
| 04/07/2011 | US20110082141 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 04/07/2011 | US20110082139 Substituted 8-[6-amino-3-pyridyl]xanthines |
| 04/07/2011 | US20110082134 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 04/07/2011 | US20110082131 Triazole derivatives useful as axl inhibitors |
| 04/07/2011 | US20110082130 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues |
| 04/07/2011 | US20110082120 Substituted thioacetic acid salicylate derivatives and their uses |
| 04/07/2011 | US20110082119 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis |
| 04/07/2011 | US20110082108 Peptidomimetic Inhibitors of Post-Proline Cleaving Enzymes |
| 04/07/2011 | US20110082107 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 04/07/2011 | US20110082103 Anoectochilus SPP. polysaccharide extracts for stimulating growth of advantageous bacteria, stimuating release of granulocyte colony-Stimulating factor, modulating T helper cell type I, and/or modulating T helper cell type II and uses of the same |
| 04/07/2011 | US20110082097 Amino acid composition for improving glucose tolerance |
| 04/07/2011 | US20110082080 Compositions and methods of using the human proislet peptide receptor |
| 04/07/2011 | US20110082079 Glucagon-like peptide-1 derivatives and their pharmaceutical use |
| 04/07/2011 | US20110082078 Methods and compositions for treating neuropathies |
| 04/07/2011 | US20110082077 Sialic acid derivatives for protein derivatisation and conjugation |
| 04/07/2011 | US20110082073 Modified Cpn10 and PRR signalling |
| 04/07/2011 | US20110081428 Use of thioflavin-like compounds to increase life span and/or health span |
| 04/07/2011 | US20110081426 Aminothiazole modulators of beta-3-adrenoreceptor |
| 04/07/2011 | US20110081424 Nutritional composition for bariatric surgery patients |
| 04/07/2011 | US20110081418 Transdermal absorption enhancer |
| 04/07/2011 | US20110081400 Nutritional composition for bariatric surgery patients |
| 04/07/2011 | US20110081369 Immune modulation with death receptor-induced apoptosis |
| 04/07/2011 | US20110081338 Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammation |
| 04/07/2011 | US20110081329 Amino acid compositions |
| 04/07/2011 | US20110081328 Use of selected lactic acid bacteria for reducing atherosclerosis |
| 04/07/2011 | US20110081320 Treatment/Cure of Autoimmune Disease |
| 04/07/2011 | US20110081319 Composition and use of phyto-percolate for treatment of disease |
| 04/07/2011 | CA2776529A1 Synthetic myostatin peptide antagonists |
| 04/07/2011 | CA2776296A1 Therapeutic uses of pharmaceutical compositions |
| 04/07/2011 | CA2776294A1 Pyrazole derivatives which modulate stearoyl-coa desaturase |
| 04/07/2011 | CA2775976A1 Bifidobacterium longum atcc baa-999 (bl999) and weight control |
| 04/07/2011 | CA2775945A1 Use of sirna targetting sipa1l1 for the reduction of adipogenesis |
| 04/07/2011 | CA2775840A1 Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts |
| 04/07/2011 | CA2775309A1 Novel phenol derivative |
| 04/07/2011 | CA2774552A1 Drug fusions and conjugates with extended half life |
| 04/06/2011 | EP2305822A2 Methods and compositions for diseases associated with Amyloidosis |
| 04/06/2011 | EP2305795A1 Method of collecting placental stem cells |
| 04/06/2011 | EP2305715A2 Monoclonal antibody to osteoprotegerin binding protein |
| 04/06/2011 | EP2305714A2 Anti-interferon-alpha subtypes antibodies |
| 04/06/2011 | EP2305713A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305712A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305694A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 04/06/2011 | EP2305684A1 Poycyloalkylpurines as adenosine receptor antagonists |
| 04/06/2011 | EP2305678A1 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof |
| 04/06/2011 | EP2305674A1 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| 04/06/2011 | EP2305673A1 Crystal of thiazolidinedione compound, and process for production thereof |
| 04/06/2011 | EP2305648A1 Amide derivatives useful as glucokinase activators |
| 04/06/2011 | EP2305352A1 5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders |
| 04/06/2011 | EP2305314A2 Remodelling and glycoconjugation of antibodies |
| 04/06/2011 | EP2305313A2 Remodelling and glycoconjugation of interferon-alpha (IFNa) |
| 04/06/2011 | EP2305312A2 Remodelling and glycoconjugation of follicle-stimulating hormone (FSH) |
| 04/06/2011 | EP2305311A2 Glycoconjugation of peptides |
| 04/06/2011 | EP2305288A2 Acidic insulin preparations with improved stability |
| 04/06/2011 | EP2305281A1 Composition comprising a hot water extract of hemerocallis plants, said composition being effective in treating fatigue by having antidepressant properties or by improving sleep |
| 04/06/2011 | EP2305276A2 Processed lipoaspirate cells for use in therapy |
| 04/06/2011 | EP2305251A2 Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of sexual disorder |
| 04/06/2011 | EP2305233A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/06/2011 | EP2305232A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/06/2011 | EP2305231A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/06/2011 | EP2305228A1 Combination therapy for the treatment of hyperlipidemia |
| 04/06/2011 | EP2305227A1 Combination therapy for the treatment of diabetes |
| 04/06/2011 | EP2305226A1 Combination therapy for the treatment of sleep apnea |
| 04/06/2011 | EP2305222A1 Compositions and methods for enhancing the antioxidant status of animals |
| 04/06/2011 | EP2305213A2 The treatment of small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 04/06/2011 | EP2304444A1 Modulators of stat3 signalling |
| 04/06/2011 | EP2304049A1 Method of treatment of vascular complications |
| 04/06/2011 | EP2303879A1 7-azaindole derivatives |
| 04/06/2011 | EP2303859A2 Aryl gpr119 agonists and uses thereof |
| 04/06/2011 | EP2303313A2 Exendins to lower cholestrol and triglycerides |
| 04/06/2011 | EP2303311A1 Use of angiogenin or angiogenin agonists for treating diseases and disorders |
| 04/06/2011 | EP2303297A1 Water-soluble extracts of artemisia dracunculus (tarragon) for improvement of glucose metabolism |
| 04/06/2011 | EP2303279A1 Topical steroidal formulations |
| 04/06/2011 | EP2303257A1 Rosmarinic acid from origanum vulgare for treatment of diabetes |
| 04/06/2011 | EP2303252A1 Compounds for the treatment of metabolic syndrome and insulin resistance |
| 04/06/2011 | EP2303247A2 Transdermal system for extended delivery of incretins and incretin mimetic peptides |
| 04/06/2011 | EP2303226A2 Sustained delivery of exenatide and other polypeptides |
| 04/06/2011 | EP2303040A1 Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon |
| 04/06/2011 | EP2303025A1 Methods for treating visceral fat conditions |
| 04/06/2011 | EP2303023A1 Improved turfgrass fungicide formulation with pigment |
| 04/06/2011 | EP1841781B1 Il-22 for use in the treatment of obesity, diabetes, hyperlipidemia, hyperglycemia and hyperinsulinemia |
| 04/06/2011 | EP1628968B1 4-imidazolin-2-one compounds |
| 04/06/2011 | EP1303479B1 7-, 8- and 9-substituted tetracycline compounds |
| 04/06/2011 | CN1993119B Composition containing statins and omega-3 fatty acids |
| 04/06/2011 | CN1376146B Solid-state form of celecoxil having enhanced bioavailability |
| 04/06/2011 | CN102007138A Hemifumarate of a pyrazole derivative |
| 04/06/2011 | CN102007126A Compounds and compositions as modulators of gpr119 activity |
| 04/06/2011 | CN102007123A Heterocyclic inhibitors of stearoyl-CoA desaturase |
| 04/06/2011 | CN102007118A Pyrrolidinone glucokinase activators |
| 04/06/2011 | CN102007116A Pyridazinone glucokinase activators |
| 04/06/2011 | CN102007105A 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 04/06/2011 | CN102007100A Compounds and compositions as modulators of GPR119 activity |
| 04/06/2011 | CN102006870A Compounds and compositions as modulators of gpr119 activity |
| 04/06/2011 | CN102006869A Treatment of energy utilization disease |
| 04/06/2011 | CN102002104A Anti-VEGF monoclonal antibody and medicinal composition containing same |
| 04/06/2011 | CN102002095A Microwave irradiation solid phase synthesis of balsam pear hypoglycemic MC-JJ0108 polypeptide analogue and application thereof |
| 04/06/2011 | CN102000345A Complex folic acid/beta-cyclodextrin composite and preparation method thereof |
| 04/06/2011 | CN102000325A Pramlintide buccal tablets and preparation method thereof |